Lesion of the median raphe nucleus: A combined behavioral and microdialysis study in rats

Pharmacology Biochemistry and Behavior

Volumn 65, Issue 1, 2000, Pages 15-21

  Thomas, Heike ^a   Fink, Heidrun ^b   Sohr, Reinhard ^a   Voits, Mechthild ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

5,7 Dihydroxytryptamine; Elevated plus maze; Hippocampus; Median raphe nucleus; Microdialysis; Rat; Serotonin

Indexed keywords

5,7 DIHYDROXYTRYPTAMINE; DESIPRAMINE; FENFLURAMINE; SEROTONIN;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; MALE; MAZE TEST; MEDIAN RAPHE NUCLEUS; MICRODIALYSIS; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE;

5,7-DIHYDROXYTRYPTAMINE; ANIMALS; BEHAVIOR, ANIMAL; HIPPOCAMPUS; MALE; MAZE LEARNING; MICRODIALYSIS; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN;

EID: 0033965161     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00119-7     Document Type: Article

References (37)

1. Andrews N., Hogg S., Gonzalez L.E., File S.E. 5-HT-1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. Eur. J. Pharmacol. 264:1994;259-264.
2. Asin K.E., Wirtshafter D., Fibiger H.C. Electrolytic, but not 5,7-dihydroxytryptamine, lesions of the nucleus medianus raphe impair acquisition of a radial maze task. Behav. Neural Biol. 44:1985;415-424.
3. Azmitia E.C., Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe. J. Comp. Neurol. 179:1978;641-668.
4. Bendotti C., Servadio A., Forloni G., Angeretti N., Samanin R. Increased tryptophan hydroxylase mRNA in raphe serotonergic neurons spared by 5,7-dihydroxytryptamine. Mol. Brain Res. 8:1990;343-348.
5. Briley M., Chopin P., Moret C. Effect of serotonergic lesion on "anxious" behavior measured in the elevated plus-maze test in the rat. Psychopharmacology (Berlin). 101:1990;187-189.
6. Carli M., Prontera C., Samanin R. Evidence that central 5-hydroxytryptaminergic neurons are involved in the anxiolytic activity of buspirone. Br. J. Pharmacol. 96:1989;829-836.
7. 1A receptor agonist. Psychopharmacology (Berlin). 94:1988;84-91.
8. Critchley M.A.E., Njung'e K., Handley S.L. Actions and some interactions of 5-HT-1A ligands in the elevated X-maze and effects of dorsal raphe lesions. Psychopharmacology (Berlin). 106:1992;484-490.
9. Deakin J.F., Graeff F.G. Critique. 5-HT and mechanisms of defence J. Psychopharmacol. 5:1991;305-315.
10. File S.E., Hyde J.R.G., MacLeod N.K. 5,7-Dihydroxytryptamine lesions of dorsal and median raphe nuclei and performance in the social interaction test of anxiety and in a home-cage aggression test. J. Affect. Disord. 1:1979;115-122.
11. Frankfurt M., Mendelson S.D., McKittrick C.R., McEwen B.S. Alterations of serotonin receptor binding in the hypothalamus following acute denervation. Brain Res. 60:1993;349-352.
12. Graeff F.G., Guimaraes F.S., de Andrade T.G.C.S., Deakin J.F.W. Role of 5-HT in stress, anxiety, and depression. Pharmacol. Biochem. Behav. 54:1996;129-141.
13. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol. Biochem. Behav. 54:1996;21-30.
14. Kirby L.G., Kreiss D.S., Singh A., Lucki I. Effect of destruction of serotonin neurons on basal and fenfluramine-induced serotonin release in striatum. Synapse. 20:1995;99-105.
15. König J.F.R., Klippel R.A. A stereotactic atlas. 1963;Williams & Wilkins, Baltimore.
16. Lopez-Rubalcava C., Fernandez-Guasti A. Noradrenaline-serotonin interactions in the anxiolytic effects of 5-HT-1A agonists. Behav. Pharmacol. 5:1994;42-51.
17. Lorens S.A., Guldenberg H.C., Hole K., Kohler C., Srebro B. Activity, avoidance learning and regional 5-hydroxytryptamine following intra-brain stem 5,7-dihydroxytryptamine and electrolytic midbrain raphe lesions in the rat. Brain Res. 108:1976;97-113.
18. Manrique C., Segu L., Héry F., Hery M., Faudon M., Francois-Bellan A.M. Increase of central 5-HT-1B binding sites following 5,7-dihydroxytryptamine axotomy in the adult rat. Brain Res. 623:1993;345-348.
19. Marsden C.A., Beckett S.R.G., Wilson W., Bickerdike M., Fink H., Rex A., Cadogan A.-K. Serotonin involvement in animal models of anxiety and panic. Takade A., Curzon G. Serotonin in the central nervous system and periphery. 1995;135-143 Elsevier, Amsterdam.
20. Patel T.D., Azmitia E.C., Zhou F.C. Increased 5-HT-1A receptor immunoreactivity in the rat hippocampus following 5,7-dihydroxytryptamine lesions in the cingulum bundle and fimbria-fornix. Behav. Brain Res. 73:1996;319-323.
21. Paxinos G., Watson C. The brain stereotaxic coordinates. 1986;Academic Press, New York.
22. Picazo O., López-Rubalcava C., Fernández-Guasti A. Anxiolytic effect of the 5-HT-1A compounds 8-hydroxy-2-(di-n-propylamine)tetralin and ipsapirone in the social interaction paradigm. Evidence of a pre-synaptic action Brain Res. Bull. 37:1995;169-175.
23. Rex A., Marsden C.A., Fink H. Effect of diazepam on cortical 5-HT release and behavior in the guinea-pig on exposure to the elevated plus maze. Psychopharmacology (Berlin). 110:1993;490-496.
24. 1C receptors in the rat brain. Neuroscience. 56:1993;687-693.
25. Rodgers R.J., Cole J.C. The elevated plus-maze. Pharmacology, methodology and ethology Cooper S.J., Hendrie C.A. Ethology and psychopharmacology. 1994;9-44 John Wiley & Sons Ltd, New York.
26. Romero L., Jernej B., Bel N., Cicin-Sain L., Cortés R., Artigas F. Basal and stimulated extracellular serotonin concentration in the brain of rats with altered serotonin uptake. Synapse. 28:1998;313-321.
27. Saito H., Matsumoto M., Togashi H., Yoshioka M. Functional interaction between serotonin and other neuronal systems. focus on in vivo microdialysis studies Jpn. J. Pharmacol. 70:1996;203-225.
28. Schreiber R., De Vry J. Neuronal circuits involved in the anxiolytic effects of the 5-HT-1A receptor agonists 8-OH-DPAT, ipsapirone and buspirone in the rat. Eur. J. Pharmacol. 249:1993;341-351.
29. Shimizu H., Tatsuno T., Tanaka H., Hirose A., Araki Y., Nakamura M. Serotonergic mechanisms in anxiolytic effect of tandospirone in the vogel conflict test. Jpn. J. Pharmacol. 59:1992;105-112.
30. Söderpalm B., Engel J.A. Involvement of the GABA-A/benzodiazepine chloride ionophore receptor complex in the 5,7-DHT induced anticonflict effects. Life Sci. 49:1991;138-153.
31. Stachowiak M.K., Stricker E.M., Jacoby J.H., Zigmond M.J. Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine. Biochem. Pharmacol. 35:1986;1241-1248.
32. Stefanski R., Palejko W., Bidtinski A., Kostowski W., Plaznik A. Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of midazolam and 5-HT-1A receptor agonist. Neuropharmacology. 32:1993;977-985.
33. Thiébot M.-H., Soubrié P., Hamon M., Simon P. Evidence against the involvement of serotonergic neurons in the anti-punishment activity of diazepam in the rat. Psychopharmacology (Berlin). 82:1984;355-359.
34. Voigt J.-P., Rex A., Sohr R., Fink H. Hippocampal 5-HT and NE release in the transgenic rat TGR(mREN2)27 related to behavior on the elevated plus maze. Eur. Neuropsychopharmacol. 9:1999;279-285.
35. Wright I.K., Upton N., Marsden C.A. Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behavior on the elevated X-maze. Psychopharmacology (Berlin). 109:1992;338-346.
36. Zhou F.C., Azmitia E.C. Induced homotypic collateral sprouting of serotonergic fibers in the hippocampus of rat. Brain Res. 308:1984;53-62.
37. Zhou F.C., Azmitia E.C. Induced homotypic sprouting of serotonergic fibers in hippocampus. II. An immunocytochemistry study. Brain Res. 373:1986;337-348.